The Latest Breaking News from Epilepsy

Penny, aged 4, suffers from Dravet Syndrome

Paige Slocombe, aged nine, has spent four years suffering from seizures every two weeks as a result of a rare condition.

The vulnerable pensioner has fortunately now been located

Last week, Addex Therapeutics Ltd (NASDAQ:ADXN) terminated the Phase 2b/3 study evaluating dipraglurant as a potential treatment for dyskinesia associated with Parkinson's disease (PD-LID) due to the slow rate of patient recruitment.  Addex is suspending its financial guidance. Hence HC Wainwright downgraded its rating to Neutral from Buy without a price target, as dipraglurant…

Here's a roundup of top developments in the biotech space over the last 24 hours:

Xenon Pharmaceuticals Inc (NASDAQ:XENE) announced new efficacy data supporting the Phase 3 development of XEN1101. XEN1101 rapidly reduced focal onset seizure frequency within one week for all doses compared with placebo.  At Week 1, the median percent reduction in monthly focal onset seizure frequency was 55.4% in the 25 mg group, 41.5% (20…

John O'hare suffers from epilepsy and a chronic lung condition that has forced him to shield for the past two years in his flat. He will soon be forced to give up his beloved pet tortoise as bills make it impossible to keep

One lady has opened up about life with diabetes

This year's tournament in memory of 11-year-old Natalie Hughes raised more than £13,000.